XML 39 R19.htm IDEA: XBRL DOCUMENT v3.25.0.1
Note 11 - Stock-based Compensation
12 Months Ended
Dec. 31, 2024
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

NOTE 11: STOCK-BASED COMPENSATION

 

A summary of outstanding options as of December 31, 2024 is included below:

 

Time Vesting Options

      

Weighted

             
      

Average

  

Weighted

      

Weighted

 
      

Remaining

  

Average

      

Average

 

Range of Exercise

 

Number

  

Contractual

  

Exercise

  

Options

  

Exercise

 

Prices between

 

Outstanding

  

Life

  

Price

  

Exercisable

  

Price

 

$4.01 - $8.00

  506,672   5.66  $7.40   506,672  $7.40 

8.01+

  85,225   1.20   22.51   85,225   22.51 
   591,897   5.01  $9.58   591,897  $9.58 

 

Performance Vesting Options

      

Weighted

             
      

Average

  

Weighted

      

Weighted

 
      

Remaining

  

Average

      

Average

 

 

 Number  Contractual  Exercise  Options  Exercise 

 

 

Outstanding

  

Life

  

Price

  

Exercisable

  

Price

 

 

  240,000   5.42  $7.59   240,000  $7.59 

 

Market Vesting Options

      

Weighted

             
      

Average

  

Weighted

      

Weighted

 
      

Remaining

  

Average

      

Average

 

 

  Number   Contractual   Exercise   Options   Exercise 

 

 

Outstanding

  

Life

  

Price

  

Exercisable

  

Price

 

 

  733,334   7.46  $3.00   -  $- 

 

  

Market Vesting Options

  

Time Vesting Options

  

Performance Vesting Options

 
      

Weighted

      

Weighted

      

Weighted

 
      

Average

      

Average

      

Average

 
  

Options

  

Exercise

  

Options

  

Exercise

  

Options

  

Exercise

 

Date/Activity

 

Outstanding

  

Price

  

Outstanding

  

Price

  

Outstanding

  

Price

 

Balance, December 31, 2023

  733,334   3.00   662,798   10.00   240,000  $7.59 

Granted

  -   -   -   -   -   - 

Forfeited or expired

  -   -   (70,901)  13.56   -   - 

Balance, December 31, 2024

  733,334   3.00   591,897   9.57   240,000  $7.59 

 

The weighted average remaining contractual life for options exercisable is 5.1 years as of December 31, 2024.

 

Shares authorized for issuance under the Company's 2014 Stock Incentive Plan is 2,000,000. There are 1,565,231 options outstanding under the 2014 Stock Incentive Plan. The Company’s ability to issue new awards under its 2014 Stock Incentive Plan expired in 2023.

 

On October 18, 2024, the Company’s shareholders approved the Company’s 2023 Stock Incentive Plan, which authorizes the issuance of up to 2,500,000 shares.  No awards have been issued under the Plan as of December 31, 2024.

 

Employee Awards

 

Stock-based compensation expense recognized for the issuance of stock options to employees for the years ended  December 31, 2024 and 2023 of $13 and $383, respectively, was included in general and administrative expense in the Consolidated Financial Statements.

 

At December 31, 2024, there was $2 of total unrecognized compensation expense related to unvested share-based awards with market vesting criteria for employees. Compensation expense related to market vesting options will be recognized over the next 1.5 months and will be adjusted for any future forfeitures as they occur. The fair value of options on the grant date varied between $0.63 and $1.11 per award as determined using the Monte Carlo model.

 

Non-Employee Awards

 

Compensation expense recognized for the issuance of stock options, including those options awarded to our Board of Directors, for the years ended  December 31, 2024 and 2023 of $0 and $150, respectively, was included in general and administrative expense in the Consolidated Financial Statements. At December 31, 2024, there was no unrecognized compensation expense related to share-based awards to non-employees.